Your browser doesn't support javascript.
loading
Aberrant hyperexpression of the RNA binding protein FMRP in tumors mediates immune evasion.
Zeng, Qiqun; Saghafinia, Sadegh; Chryplewicz, Agnieszka; Fournier, Nadine; Christe, Lucine; Xie, Yu-Qing; Guillot, Jeremy; Yucel, Simge; Li, Pumin; Galván, José A; Karamitopoulou, Eva; Zlobec, Inti; Ataca, Dalya; Gallean, Fleuriane; Zhang, Peng; Rodriguez-Calero, José Antonio; Rubin, Mark; Tichet, Mélanie; Homicsko, Krisztian; Hanahan, Douglas.
Afiliación
  • Zeng Q; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), 1015 Lausanne, Switzerland.
  • Saghafinia S; Opna Bio SA, Biopole, 1066 Epalinges, Lausanne, Switzerland.
  • Chryplewicz A; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), 1015 Lausanne, Switzerland.
  • Fournier N; Opna Bio SA, Biopole, 1066 Epalinges, Lausanne, Switzerland.
  • Christe L; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), 1015 Lausanne, Switzerland.
  • Xie YQ; Agora Cancer Research Center, 1011 Lausanne, Switzerland.
  • Guillot J; Swiss Institute of Bioinformatics (SIB), 1015 Lausanne, Switzerland.
  • Yucel S; Institute of Pathology, University of Bern, 3008 Bern, Switzerland.
  • Li P; Institute of Bioengineering, School of Engineering, Swiss Federal Institute of Technology Lausanne (EPFL), 1015 Lausanne, Switzerland.
  • Galván JA; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), 1015 Lausanne, Switzerland.
  • Karamitopoulou E; Agora Cancer Research Center, 1011 Lausanne, Switzerland.
  • Zlobec I; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), 1015 Lausanne, Switzerland.
  • Ataca D; Agora Cancer Research Center, 1011 Lausanne, Switzerland.
  • Gallean F; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), 1015 Lausanne, Switzerland.
  • Zhang P; Agora Cancer Research Center, 1011 Lausanne, Switzerland.
  • Rodriguez-Calero JA; Department of Computational Biology, University of Lausanne, 1015 Lausanne, Switzerland.
  • Rubin M; Institute of Pathology, University of Bern, 3008 Bern, Switzerland.
  • Tichet M; Institute of Pathology, University of Bern, 3008 Bern, Switzerland.
  • Homicsko K; Institute of Pathology, University of Bern, 3008 Bern, Switzerland.
  • Hanahan D; Opna Bio SA, Biopole, 1066 Epalinges, Lausanne, Switzerland.
Science ; 378(6621): eabl7207, 2022 11 18.
Article en En | MEDLINE | ID: mdl-36395212
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína de la Discapacidad Intelectual del Síndrome del Cromosoma X Frágil / Evasión Inmune / Tolerancia Inmunológica / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Science Año: 2022 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína de la Discapacidad Intelectual del Síndrome del Cromosoma X Frágil / Evasión Inmune / Tolerancia Inmunológica / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Science Año: 2022 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos